The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
li tuo xi dan kang lian he hua liao zhi liao cd+20 de b xi bao xing fei huo qi jin lin ba liu de hu li
Author(s): 
Pages: 4171
Year: Issue:  17
Journal: CHINESE JOURNAL OF MISDIAGNOSIS

Keyword:  淋巴瘤B细胞/药物疗法/护理抗体单克隆/治疗应用药物疗法联合人类;
Abstract: 目的:探讨利妥昔单抗(商品名:美罗华)联合CHOP(环磷酰胺、长春新碱、多柔比星、泼尼松)化疗方案治疗CD+20非霍奇金淋巴瘤(NHL)的疗效及毒副作用.方法:化疗使用CHOP方案,联合第1天使用美罗华375 mg/m2,第2天行CHOP方案.结果:治疗效果明显,毒副作用小于传统化疗方案.结论:美罗华联合化疗可改善NHL患者的预后,取得了良好效果,提高了患者的生存期,且毒副作用小.
Related Articles
No related articles found